Pharma Facing Pressure to Renegotiate COVID-19 Vaccine Contracts with EU Govts

As the demand for COVID-19 vaccines dwindle in Europe, many EU nations’ governments look to renegotiate their vaccine deals with manufacturers to reduce the doses they will purchase in the upcoming months. Manufacturers have resisted such requests, with Pfizer describing a letter from several nations governments as “an insufficient solution” to the issue.

According to Fleur Jeffries, “The letter stated that “we witness excessive burden on state budgets, combined with delivery of unnecessary amounts of vaccines” and then cautioned “there is a high probability that doses supplied to the European Union might end up being disposed of.”

To learn more, click here.

(Source: PM Live, June 15, 2022)